Public Company News

Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited

SHANGHAI, March 1, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...

2021-03-01 12:36 5629

AVerMedia Launches Standalone Capture Box "EzRecorder 330" with PC-Free Streaming and Cross-Generational Gameplay Support

NEW TAIPEI CITY, Taiwan, March 1, 2021 /PRNewswire/ -- AVerMedia Technologies, Inc. (stock code: 2417), an audio and video expert, launches theEzRecorder 330 (ER330) -- a standalone capture box with 4K pass-through, allowing users to record 1080p Full HD and live-stre...

2021-03-01 10:30 2709

China Renaissance Announces Positive Profit Update

Expects to Record a 310.8% YoY Increase in Profit Attributable to Owners of the Company for the Year EndedDecember 31, 2020 HONG KONG, March 1, 2021 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Company"; stock code: 1911.HK) announced today that, based on the p...

2021-03-01 10:14 6646

AvePoint Launches EduTech To Improve Higher Education Technology

EDBI Named as One of Several New AvePoint, Inc. Investors as Company Moves Toward Public Listing SINGAPORE, March 1, 2021 /PRNewswire/ -- AvePoint, Inc., one of the largest Microsoft 365 data management solutions providers, announced today the global launch of AvePoint EduTech. The Singapore in...

2021-03-01 09:30 5066

Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody

SAN FRANCISCO and SUZHOU, China, March 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-03-01 08:23 7514

Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index

SHANGHAI and HONG KONG, March 1, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-03-01 08:00 3264

Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index

SHANGHAI and HONG KONG, Feb. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-03-01 08:00 6288